InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001773751-24-000041 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-01 2024-02-29 HIMS Dudum Andrew CEO, Dir, 10% S - Sale+OE $12.96 -577.0K 51.7K -92% -$7.48M
D 2024-03-01 2024-02-29 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $2.43 +577.0K 628.7K +1,117% +$1.40M
D 2024-03-01 2024-02-28 HIMS Dudum Andrew CEO, Dir, 10% A - Grant $0.00 +1.19M 1.19M New $0
D 2024-03-01 2024-02-29 HIMS Dudum Andrew CEO, Dir, 10% M - OptEx $0.00 -577.0K 1.90M -23% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-02-29 S D 577,007 $12.96 51,653 D — —
2 Common Class A Common Stock 2024-02-29 M A 577,007 $2.43 628,660 D — —
3 Derivative Restricted Stock Unit 2024-02-28 A A 1,192,477 $0.00 1,192,477 D — · — to — 1,192,477 Class A Common Stock (F2) The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. (F3) The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
4 Derivative Stock Option (right to buy) 2024-02-29 M D 577,007 $0.00 1,904,016 D $2.43 · — to 2030-06-17 577,007 Class A Common Stock (F4) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.